Related Experiment Videos
Dermatologic lupus: Hopkins Lupus Cohort
1Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Seminars in Cutaneous Medicine and Surgery
|October 6, 1998
Summary
Dermatologic manifestations are common in systemic lupus erythematosus (SLE). This study offers insights into SLE
Area of Science:
- Rheumatology
- Dermatology
- Epidemiology
Background:
- Dermatologic manifestations are frequent in systemic lupus erythematosus (SLE).
- Understanding these skin signs is crucial for diagnosis and management.
- Antiphospholipid antibody syndrome (APS) also presents with dermatologic findings.
Purpose of the Study:
- To present insights from the Hopkins Lupus Cohort study on SLE.
- To detail the epidemiologic factors and presentation of dermatologic lupus.
- To review dermatologic signs of APS and discuss treatment approaches.
Main Methods:
- Prospective observational study (Hopkins Lupus Cohort).
- Quarterly assessments of disease activity, laboratory tests, morbidity, and quality of life.
- Review of dermatologic manifestations in SLE and APS.
Main Results:
- The cohort provides unique insights into SLE epidemiology and dermatologic lupus presentation.
- Morbidity associated with SLE is assessed.
- Dermatologic signs of APS are reviewed.
Conclusions:
- Dermatologic manifestations are key indicators in SLE and APS.
- Comprehensive cohort data aids understanding of disease presentation and impact.
- Treatment strategies for dermatologic lupus and APS are discussed.